Yong-Wen Qin Selected Research

Yong-Wen Qin Research Topics

Disease

4	Ventricular Heart Septal Defects (Ventricular Septal Defect) 03/2021 - 04/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 06/2007
3	Hypertrophy 04/2012 - 07/2010
3	Cardiomegaly (Heart Hypertrophy) 04/2012 - 07/2010
2	Atherosclerosis 11/2022 - 07/2014
2	Infections 03/2021 - 11/2009
2	Pathologic Processes 12/2016 - 01/2011
2	Heart Failure 06/2015 - 12/2009
2	Cardiac Arrhythmias (Arrythmia) 10/2014 - 05/2010
2	Aortic Valve Insufficiency (Aortic Regurgitation) 12/2013 - 01/2011
2	Myocardial Infarction 03/2013 - 03/2010
2	Pathologic Constriction (Stenosis) 06/2009 - 06/2007
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 11/2022
1	Hypercholesterolemia 11/2022
1	Wounds and Injuries (Trauma) 01/2019
1	Porphyrias (Porphyria) 01/2016
1	Pulmonary Valve Stenosis (Pulmonary Stenosis) 01/2015
1	Secundum Type Atrial Septal Defect 01/2015
1	Tachycardia (Tachyarrhythmias) 10/2014
1	Sinus Tachycardia 10/2014
1	Atherosclerotic Plaque (Atheroma) 07/2014
1	Atrioventricular Block 12/2013
1	Stroke (Strokes) 12/2013
1	Hemorrhage 01/2011
1	Pulmonary Arteriovenous Fistulas 01/2011
1	Cardiac Tamponade 01/2011
1	Cyanosis 01/2011
1	Rupture 01/2011
1	Hepatopulmonary Syndrome 01/2011
1	Hypertension (High Blood Pressure) 12/2010
1	Pulmonary Valve Insufficiency (Insufficiency, Pulmonary Valve) 11/2010
1	Fibrosis (Cirrhosis) 07/2010
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 04/2010
1	Coronary Disease (Coronary Heart Disease) 03/2010
1	Cachexia 12/2009
1	Neoplasms (Cancer) 11/2009
1	Lung Neoplasms (Lung Cancer) 11/2009
1	Carcinoma (Carcinomatosis) 11/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 06/2007
1	Obesity 05/2007

Drug/Important Bio-Agent (IBA)

6	MicroRNAs (MicroRNA)IBA 12/2016 - 03/2010
3	GhrelinIBA 12/2010 - 05/2007
2	Apolipoproteins E (ApoE)IBA 11/2022 - 07/2014
2	Biomarkers (Surrogate Marker)IBA 12/2016 - 03/2010
2	Proteins (Proteins, Gene)FDA Link 04/2012 - 07/2010
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020
1	TetrapyrrolesIBA 01/2016
1	LipidsIBA 07/2014
1	Messenger RNA (mRNA)IBA 06/2011
1	salicylhydroxamic acid (SHAM)IBA 06/2011
1	MorpholinosIBA 01/2011
1	RNA (Ribonucleic Acid)IBA 01/2011
1	Oxygen (Dioxygen)IBA 01/2011
1	Hypoxia-Inducible Factor 1IBA 11/2010
1	LuciferasesIBA 11/2010
1	Circulating MicroRNAIBA 03/2010
1	N 30IBA 03/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2009
1	Stainless Steel (Steel, Stainless)IBA 04/2009
1	nitinolIBA 04/2009
1	omega-Chloroacetophenone (Mace)IBA 06/2007

Therapy/Procedure

7	Stents 06/2015 - 06/2007
3	Therapeutics 12/2016 - 11/2009
2	Radiofrequency Ablation 10/2014 - 01/2011
1	Thoracotomy 03/2021
1	Punctures 03/2021
1	Surgical Amputation (Amputations) 01/2019
1	Local Anesthesia 01/2015
1	Percutaneous Coronary Intervention 03/2013
1	Denervation 06/2011
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2011
1	Catheter Ablation 01/2011
1	Surgical Instruments (Clip) 04/2010